Sarepta Therapeutics, Inc. financial data

Symbol
SRPT on Nasdaq
Location
215 First Street, Suite 415, Cambridge, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 6, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 367 % -13.4%
Quick Ratio 110 % +85.2%
Debt-to-equity 180 % -29.5%
Return On Equity -4.42 % -185%
Return On Assets -1.58 % -209%
Operating Margin -0.04 % -101%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 97.7M shares +2.46%
Common Stock, Shares, Outstanding 97.7M shares +2.54%
Common Stock, Value, Issued 10K USD 0%
Weighted Average Number of Shares Outstanding, Basic 98M shares +3.58%
Weighted Average Number of Shares Outstanding, Diluted 107M shares +7.54%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 2.48B USD +64.9%
Revenue from Contract with Customer, Excluding Assessed Tax 2.19B USD +57.2%
Costs and Expenses 2.48B USD +69.2%
Operating Income (Loss) -932K USD -102%
Nonoperating Income (Expense) -23.2M USD -196%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -24.1M USD -139%
Income Tax Expense (Benefit) 33.8M USD +127%
Net Income (Loss) Attributable to Parent -58M USD -223%
Earnings Per Share, Basic 0 USD/shares -173%
Earnings Per Share, Diluted 0 USD/shares -205%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 511M USD +33.1%
Cash, Cash Equivalents, and Short-term Investments 1.69B USD -15.8%
Accounts Receivable, after Allowance for Credit Loss, Current 527M USD +46.5%
Inventory, Net 994M USD +105%
Other Assets, Current 128M USD +70.7%
Assets, Current 2.66B USD -0.99%
Property, Plant and Equipment, Net 372M USD +34.6%
Operating Lease, Right-of-Use Asset 143M USD +15.4%
Other Assets, Noncurrent 83.1M USD -38.7%
Assets 3.68B USD +7.46%
Accounts Payable, Current 137M USD +27.3%
Employee-related Liabilities, Current 55.2M USD +10.4%
Accrued Liabilities, Current 377M USD +7.7%
Contract with Customer, Liability, Current 395M USD +224%
Liabilities, Current 920M USD +33.6%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Operating Lease, Liability, Noncurrent 214M USD +49.3%
Other Liabilities, Noncurrent 1.2M USD -83%
Liabilities 2.32B USD -1.06%
Accumulated Other Comprehensive Income (Loss), Net of Tax -51K USD +95%
Retained Earnings (Accumulated Deficit) -4.46B USD -1.32%
Stockholders' Equity Attributable to Parent 1.36B USD +26%
Liabilities and Equity 3.68B USD +7.46%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -583M USD -141%
Net Cash Provided by (Used in) Financing Activities 12.5M USD -43.7%
Net Cash Provided by (Used in) Investing Activities -291M USD -233%
Common Stock, Shares Authorized 198M shares 0%
Common Stock, Shares, Issued 98.4M shares +3.23%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -862M USD -75527%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 526M USD +31.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 7.19M USD 0%
Deferred Tax Assets, Valuation Allowance 888M USD +0.53%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure
Deferred Tax Assets, Gross 923M USD +1.21%
Operating Lease, Liability 206M USD +29.6%
Payments to Acquire Property, Plant, and Equipment 43.7M USD +34.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -57M USD -220%
Lessee, Operating Lease, Liability, to be Paid 382M USD -4.11%
Property, Plant and Equipment, Gross 574M USD +37.4%
Operating Lease, Liability, Current 13.3M USD -25.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 31.5M USD -8.55%
Lessee, Operating Lease, Liability, to be Paid, Year One 31.8M USD -5.81%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure -11%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 177M USD -26.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 31.6M USD +12.7%
Deferred Tax Assets, Operating Loss Carryforwards 67.6M USD -56.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 3.33M shares 0%
Unrecognized Tax Benefits 66.5M USD +2.31%
Lessee, Operating Lease, Liability, to be Paid, Year Four 32.3M USD +15.3%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 11.1M USD
Current Federal Tax Expense (Benefit) 4.18M USD
Amortization of Intangible Assets 2.47M USD +2.79%
Depreciation, Depletion and Amortization 9.98M USD +14.1%
Share-based Payment Arrangement, Expense 37M USD -26.7%
Interest Expense -18.3M USD +44.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%